Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Supportive Medicines - Alfentanil 25mg/50ml vial - Direct Award

  • First published: 18 March 2022
  • Last modified: 18 March 2022
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security
Authority ID:
AA82243
Publication date:
18 March 2022
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

The Department of Health and Social Care managed the procurement on behalf of the UK Health Security Agency for the supply of Alfentanil 25mg/50ml solution for injection (ITU) in preparation for further waves of Covid 19 in Spring 2022. The contract was awarded on the behalf of UK Health Security Agency.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Nobel House, 17 Smith Square

London

SW1P 3JR

UK

Contact person: Simeon Hadebe

E-mail: dhsc.covidmeds@dhsc.gov.uk

NUTS: UKI32

Internet address(es)

Main address: https://www.gov.uk/government/organisations/uk-health-security-agency

Address of the buyer profile: https://www.gov.uk/government/organisations/uk-health-security-agency

I.4) Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Supportive Medicines - Alfentanil 25mg/50ml vial - Direct Award

Reference number: CM / EMI / 21/ C59263

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

For the supply of Alfentanil 25mg/50ml solution for injection (ITU) in preparation for further waves of Covid 19 in Spring 2022.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 1.00  GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

The Department of Health and Social Care managed the procurement on behalf of the UK Health Security Agency for the supply of Alfentanil 25mg/50ml solution for injection (ITU) in preparation for further waves of Covid 19 in Spring 2022. The contract was awarded on the behalf of UK Health Security Agency.

II.2.5) Award criteria

Quality criterion: Availability / Weighting: 100

Cost criterion: Price / Weighting: 0

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Award of a contract without prior publication of a call for competition

Justification for selected award procedure:

The works, supplies or services can be provided only by a particular economic operator for the following reason: absence of competition for technical reasons

Explanation

The supportive medicines stockpile was designed as a ‘one off’ build to target volumes of a defined range of critical products. However, ongoing concerns regarding the disease and additional waves have caused the Department to prepare for further waves of COVID-19 in Winter 2021/Spring 2022.<br/>The recent developments around the Omicron variant have prompted activation for additional volumes identified through the modelling as necessary to avoid complete stockout of some products through Winter 2021/Spring 2022.<br/>One of those critical products is Alfentanil which has seen markedly increased usage during the pandemic and the need to secure stock has become paramount. There is only one supplier in the market able to produce this strength of Alfentanil. Accordingly, the Contracting Authority used the negotiated procedure without prior publication route to make a Direct Award on the basis of Regulation 32(2)(b)(ii) – Competition is absent for technical reasons – permitted under the Public Contract Regulations 2015 (as amended) to conduct this procurement.

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

21/02/2022

V.2.2) Information about tenders

Number of tenders received: 1

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Hameln pharma ltd

01034697

Unit C, Nexus, Gloucester Business Park, Gloucester, Gloucestershire

Gloucester

GL3 4AG

UK

NUTS: UK

Internet address(es)

URL: http://www.hameln.co.uk

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: : 1.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per vial. This will (i) commercially prejudice the contracting authority in its commercial dealings with other suppliers; and (ii) impact fair competition between suppliers.

VI.4) Procedures for review

VI.4.1) Review body

The High Court

Strand

London

WC2A 2LL

UK

E-mail: generaloffice@administrativecourtoffice.justice.gov.uk

Internet address(es)

URL: https://www.gov.uk/courts-tribunals

VI.5) Date of dispatch of this notice

17/03/2022

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
dhsc.covidmeds@dhsc.gov.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.